K
Kerstin Elvin
Researcher at Karolinska University Hospital
Publications - 43
Citations - 1547
Kerstin Elvin is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Pneumocystis carinii & Population. The author has an hindex of 19, co-authored 43 publications receiving 1391 citations. Previous affiliations of Kerstin Elvin include Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
Maryam Dastmalchi,Cecilia Grundtman,Helene Alexanderson,Clio P. Mavragani,H Einarsdottir,S Barbasso Helmers,Kerstin Elvin,Mary K. Crow,Inger Nennesmo,Ingrid E. Lundberg +9 more
TL;DR: Infliximab treatment was not effective in refractory inflammatory myopathies, and activation of the type I IFN system in several cases, infliximab is not an alternative treatment in patients with treatment-resistant myositis.
Journal ArticleDOI
Selective IgA Deficiency in Autoimmune Diseases
Ning Wang,Nan Shen,Timothy J. Vyse,Vidya Anand,Iva Gunnarson,Gunnar Sturfelt,Solbritt Rantapää-Dahlqvist,Kerstin Elvin,Lennart Truedsson,Bengt Andersson,Charlotte Dahle,Eva Örtqvist,Peter K. Gregersen,Timothy W. Behrens,Lennart Hammarström +14 more
TL;DR: Evidence is presented for a shared genetic predisposition between Graves disease, systemic lupus erythematosus, type 1 diabetes, celiac disease, myasthenia gravis, and rheumatoid arthritis on the basis of both large-scale screening results and literature data.
Journal ArticleDOI
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study
Johanna Gustafsson,Iva Gunnarsson,Ola Börjesson,Susanne Pettersson,S. Möller,Guo-Zhong Fei,Kerstin Elvin,Julia F. Simard,Lars-Olof Hansson,Ingrid E. Lundberg,Anders Larsson,Elisabet Svenungsson +11 more
TL;DR: The results indicate that activation of the endothelium and the coagulation system are important features in SLE related CVD and the risk of CVEs seems to differ between subgroups of SLE patients.
Journal ArticleDOI
Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study
Johanna Gustafsson,Julia F. Simard,Iva Gunnarsson,Kerstin Elvin,Ingrid E. Lundberg,Lars-Olof Hansson,Anders Larsson,Elisabet Svenungsson +7 more
TL;DR: With the exception of smoking, traditional risk factors do not capture the main underlying risk factors for CVM in SLE, and new biomarkers are suggested to be useful in evaluating the future risk of cardiovascular mortality in Sle patients.
Journal ArticleDOI
Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls
Johanna Gustafsson,Marie Herlitz Lindberg,Iva Gunnarsson,Susanne Pettersson,Kerstin Elvin,John Öhrvik,Anders Larsson,K Jensen-Urstad,Elisabet Svenungsson +8 more
TL;DR: In SLE excess carotid plaques are essentially confined to the SLE subgroup with nephritis, a more robust measure of atherosclerosis, which demonstrates the importance of careful clinical subgroup analyses when investigating heterogeneous, hitherto not clearly defined, conditions like SLE.